Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

The search for a cure news

Show

From To
Is It Ethical to Take People Off HIV Meds for Cure Research?

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

Published
13 September 2017
From
Poz
HIV Survivors Give Their 'Last Gift' In A New San Diego Study

The Last Gift study at UC San Diego is a unique new research effort focusing on HIV patients with a terminal illness such as cancer, ALS or advanced heart disease. Participants must have a prognosis of less than six months to live. When they near the end of their lives, they stop taking their HIV medications and let researchers draw blood regularly to monitor the activity of the virus. They also consent to having their bodies autopsied within hours of death.

Published
11 September 2017
From
KPBS
Looking for 'a multitude of ways to cure HIV'

HIV researchers draw hope from cancer immunotherapies — and inspiration from Timothy Ray Brown

Published
22 August 2017
From
Fred Hutch News Service
Dr. Carl June weaves together HIV and cancer research to advance cures for both

CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference.

Published
17 August 2017
From
Fred Hutch News Service
Understanding Exactly How the ‘Berlin Patient’ Was Cured

The strongest proof that HIV can be cured comes from the case of Timothy Brown, the “Berlin patient.” That triumph was predicated on physicians taking advantage of nature’s own experiment: the existence of a genetic mutation in a normal cell protein, CCR5, the main co-receptor that HIV uses to gain entry into a cell.

Published
16 August 2017
From
amfAR
Why curing HIV may be like curing cancer – and may be as difficult

For the last few years, a specialist symposium on HIV cure research has preceded the International AIDS Society (IAS) Conferences and this one was no exception,

Published
03 August 2017
By
Gus Cairns
What marks out HIV controllers from others?

The first part of this report from the 2017 IAS Cure and Cancer Forum, which was held in advance of the IAS 2017 conference, looked

Published
03 August 2017
By
Gus Cairns
Can we achieve a complete HIV cure in more patients?

What all the different approaches discussed in the previous two reports have in common is that they aim to put HIV infection into persistent remission. But

Published
03 August 2017
By
Gus Cairns
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

A broadly neutralising antibody modestly delayed the resurgence of viral replication following interruption of antiretroviral therapy (ART) started during very early infection, but all study participants ultimately experienced

Published
02 August 2017
By
Liz Highleyman
Vorinostat renders dormant HIV infection vulnerable to clearance

For the first time researchers at the University of North Carolina at Chapel Hill have developed an assay that can measure antigen production and clearance caused by a latency-reversing agent.

Published
01 August 2017
From
Eurekalert Medicine & Health
← First12345...44Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.